Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer
Clinical trial NCT04367090 · COMPLETED
Trial details
- NCT number
- NCT04367090
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2022-08-10
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.